Global impacts of COVID‐19 pandemic on sexual and reproductive health services: An international comparative study on primary care from the INTRePID Consortium

• Published in: BJOG : an international journal of obstetrics and gynaecology Vol. 131; no. 4; pp. 508 - 517
• Main Authors: Peng, Kangning, Tu, Karen, Li, Zhuo, Hallinan, Christine Mary, Laughlin, Adrian, Manski‐Nankervis, Jo‐Anne, Apajee, Jemisha, Lapadula, María Carla, Ortigoza, Angela, Da Roza, Cecilia Clara, Baste, Valborg, Flottorp, Signe, Wensaas, Knut‐Arne, Goh, Lay Hoon, Ling, Zheng Jye, Kristiansson, Robert, Gaona, Gabriela, Pace, Wilson D., Westfall, John M., Ng, Amy Pui Pui, Wong, William Chi‐Wai
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01-03-2024
• Subjects: Cancer screening; Cervical cancer; Cervix; Consortia; COVID-19; COVID-19 pandemic; Medical screening; Pandemics; Primary care; Reproductive health; sexual and reproductive health; Canada; Sweden; Singapore; United States > US; Norway; China; Australia; COVID-19 pandemic; sexual and reproductive health
• ISSN: 1470-0328; 1471-0528; 1471-0528
• DOI: 10.1111/1471-0528.17704

Objective
To understand how the COVID‐19 pandemic has impacted sexual and reproductive health (SRH) visits.
Design
An ecological study comparing SRH services volume in different countries before and after the onset of the COVID‐19 pandemic.
Setting
Seven countries from the INTernational ConsoRtium of Primary Care BIg Data Researchers (INTRePID) across four continents.
Population
Over 3.8 million SRH visits to primary care physicians in Australia, China, Canada, Norway, Singapore, Sweden and the USA.
Methods
Difference in average SRH monthly visits before and during the pandemic, with negative binomial regression modelling to compare predicted and observed number of visits during the pandemic for SRH visits.
Main outcome measures
Monthly number of visits to primary care physicians from 2018 to 2021.
Results
During the pandemic, the average volume of monthly SRH visits increased in Canada (15.6%, 99% CI 8.1–23.0%) where virtual care was pronounced. China, Singapore, Sweden and the USA experienced a decline (−56.5%, 99% CI −74.5 to −38.5%; −22.7%, 99% CI −38.8 to −6.5%; −19.4%, 99% CI −28.3 to −10.6%; and −22.7%, 99% CI −38.8 to −6.5%, respectively); while Australia and Norway showed insignificant changes (6.5%, 99% CI −0.7 to –13.8% and 1.7%, 99% CI −6.4 to –9.8%). The countries that maintained (Australia, Norway) or surpassed (Canada) pre‐pandemic visit rates had the greatest use of virtual care.
Conclusions
In‐person SRH visits to primary care decreased during the pandemic. Virtual care seemed to counterbalance that decline. Although cervical cancer screening appeared insensitive to virtual care, strategies such as incorporating self‐collected samples for HPV testing may provide a solution in a future pandemic.